by Elena Iemma | Feb 22, 2024 | Thinking Out Loud -Blog
In with the New! At this point in our evolution as a company, we can affirm that change is good! As promised, EpiVax 2.0 is emerging in 2024, with new products and new leaders! First, say hello to our new CEO, Rich-Henry Schabowsky, PhD JD. Rich-Henry is no stranger...
by Elena Iemma | Feb 22, 2024 | Thinking Out Loud -Blog
Immunogenicity assessment is key to drug safety. Currently there is no standard approach to the In Silico Immunogenicity Assessment of Therapeutic Peptides, however, the EpiVax team has worked with the FDA to develop several methods, including a validated in silico...
by Elena Iemma | Jan 30, 2024 | Featured, Thinking Out Loud -Blog
It’s Post-Pandemic and we’re back on the road traveling to the 4 corners of the Earth. Where will we get to see you? Here’s a list of upcoming events, and because … what’s travel without great food? … I’ve included some...
by Elena Iemma | Dec 20, 2023 | Featured, News
PROVIDENCE, RI, December 20, 2023 /PRNewswire/ — EpiVax, Inc. (“EpiVax”), an internationally recognized leader in the field of immunogenicity, today announced that Eisai Co. Ltd. (“Eisai”) has licensed EpiVax’s ISPRI toolkit for immunogenicity risk assessment of...
by Elena Iemma | Nov 27, 2023 | Featured, Thinking Out Loud -Blog
This is a two-way street Hey Hey, Hallo, Hola, Ciao, Namaste, Hello, Bonjour, Konnichiwa! When do you do your ‘thinking’ about the day? Do you do it while running? Well, I was thinking about you guys on my runs this week. I am finally back in Providence,...